RES 351 Week 2 Individual Assignment

RES 351 Week 2 Individual Assignment

RES 351 Week 2 Individual Assignment BY Ritterkl RUNNING HEAD:austness Research Ethics Business Research Ethics RES 351 An article was chosen from the University Library to evaluate the issue of unethical business research conduct. The article chose is called Flacking for Big Pharma: Drugmakers Don’t Just Compromise Doctors; They Also Undermine the Top Medical Journals and Skew the Findings of Medical Research . The identification of the unethical business research involved in the article is given. The parties involved along with effected party is mentioned.

The evaluation of the article also identifies ow the unethical behavior affected the organization, injured party, and society. A proposition of how the unethical behavior could be avoided is proposed. The article is based on how pharmaceutical companies are using medical research in advertising and medical Journals (Washington, 2011). The medical advertising has an with financial support to keep publishing (Washington, 2011). Health care professionals use medical Journals for use in diagnosing and treating patients.

This is not the only issue mention the article. The pharmaceutical companies are using techniques in medical research of drugs to supply the consumer with information hat makes the bad drugs look good (Washington, 2011). The companies use small groups, placebos, and test on only minimal and maximum doses (Washington, 2011). The research only allows the drugs to be tested against benefiting variables for the drug. With the statistics provided for research for medical articles, the unethical boundaries has been breached.

Because of the unethical boundaries that were breached many pharmaceutical companies have pending and tried lawsuits. The parties involved in the article is the pharmaceutical companies, health care professionals, and patients. The pharmaceutical companies are the provider of the medical research to the prescribing health care professional. The inaccuracy and unethical research provided to show how the drug is affected gives health care professionals the wrong information to prescribe to his or her patients.

The consumers receive the biggest lost because the use of wrong drug and doses can lead to other illness and even death. The unethical behavior has effected the organization, injured party, and society. The organization is effected because of the unreliability of new drugs brought to the market. With past issues with unethical practices in medical research, the prescribing health professionals are reluctant to use product. The organization loses profit and reputation because of the unethical practices some companies use.

The injured party, the patient, is affected because lost of life or developed illnesses that are not able to returned to normal state. With illness and death the individual places hardship on other family members creating a wealth of economic instability. Society is effected because new drugs are not developed to help with incurable diseases because of the past experiences, and if eveloped the health care professionals do not want to prescribe the medication because of potential lawsuit.

Society is trying to gain a healthier community but can not because the trust in pharmaceuticals is no longer valid. To avoid the unethical behavior in pharmaceutical companies a law should be proposed that sets guidelines and standards to pharmaceutical practices in medical research. The laws can govern how many different research analysis has to performed before a drug enters the market along with what information the consumers have to be supplied with when prescribing medication. Such information could be the side effects of minimal and maximum doses and the time of how long the drug is used.

A regulatory agency should be appointed to ensure that pharmaceutical companies are following new laws along with imposing consequences to those companies that do not. This will detour the pharmaceutical companies from applying unethical practices to research. In summary a unethical business research conduct article was chosen. The article chosen was Flacking for Big Pharma: Drugmakers Don’t Just Compromise Doctors; They Also Undermine the Top Medical Journals and Skew the Findings of Medical Research.

The article was an analysis of ethical research practices performed by pharmaceutical companies and the consequences of the action. The parties involved were pharmaceutical company, health care professionals, and patients. The effects of to eliminate unethical practices was proposed as well. References Washington, H. A. (2011). Flacking for Big Pharma: Drugmakers Don’t Just Compromise Doctors; They Also Undermine the Top Medical Journals and Skew the Findings of Medical Research. (cover story). American Scholar, 80(3), 22. Retrieved from EBSCOhost.